RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%

Extendicare Inc

Healthcare CA EXE

7.28CAD
-0.44(5.70%)

Last update at 2024-05-16T19:31:00Z

Day Range

7.207.72
LowHigh

52 Week Range

5.677.37
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.49600M 16.04M 58.87M 24.24M 12.32M
Minority interest - - - - -
Net income -4.51100M 9.01M 42.59M 17.05M 31.74M
Selling general administrative 1164.12M 1140.20M 48.96M 42.34M 39.75M
Selling and marketing expenses - - - - -
Gross profit 1221.58M 1216.76M 1158.29M 1131.95M 133.98M
Reconciled depreciation 32.12M 38.57M 38.80M 39.59M 35.27M
Ebit 20.99M 56.62M 93.30M 52.39M 63.56M
Ebitda 53.11M 95.19M 132.10M 91.98M 98.83M
Depreciation and amortization 32.12M 38.57M 38.80M 39.59M 35.27M
Non operating income net other - - - - -
Operating income 20.99M 56.62M 93.30M 52.39M 38.77M
Other operating expenses 1196.91M 1162.01M 1063.95M 1080.43M 1061.04M
Interest expense 20.61M 27.20M 28.48M 28.73M 27.58M
Tax provision 0.01M 7.03M 16.28M 7.18M 4.24M
Interest income 15.52M 23.74M 28.97M 23.04M 22.62M
Net interest income -15.28200M -25.03200M -27.03400M -26.88800M -26.70100M
Extraordinary items 74.06M 2.49M 11.60M 11.58M 23.65M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.01M 7.03M 16.28M 7.18M 4.24M
Total revenue 1221.58M 1216.76M 1158.29M 1131.95M 1120.01M
Total operating expenses 1196.91M 1162.01M 1063.95M 1080.43M 1061.04M
Cost of revenue 1113.05M 1070.41M 976.20M 998.50M 986.02M
Total other income expense net -25.48300M -40.58000M -34.43100M -28.15500M -26.45400M
Discontinued operations 74.06M 2.49M 11.60M 13.83M 23.65M
Net income from continuing ops -4.51100M 9.01M 42.59M 17.05M 8.08M
Net income applicable to common shares 69.55M 11.50M 54.19M 28.63M 31.74M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 781.58M 900.32M 963.13M 888.80M 896.32M
Intangible assets 51.21M 46.63M 36.50M 38.20M 43.52M
Earning assets - - - - -
Other current assets 23.98M 26.47M 40.23M 20.66M 23.75M
Total liab 680.88M 798.40M 834.94M 773.39M 770.33M
Total stockholder equity 100.70M 101.92M 128.19M 115.41M 125.99M
Deferred long term liab - - - - -
Other current liab 5.61M 15.34M 21.06M 5.18M 17.62M
Common stock 475.42M 500.88M 500.58M 498.12M 492.06M
Capital stock 475.42M 500.88M 500.58M 498.12M 492.06M
Retained earnings -384.62000M -402.45300M -370.96300M -382.18900M -368.14700M
Other liab 41.16M 52.48M 59.64M 74.28M 88.49M
Good will 45.85M 45.85M 51.67M 51.67M 51.67M
Other assets 37.76M 47.32M 52.96M 84.50M 128.74M
Cash 167.28M 104.63M 179.96M 94.46M 65.89M
Cash and equivalents 167.28M 104.63M 179.96M 94.46M 65.89M
Total current liabilities 274.99M 281.91M 279.52M 275.87M 226.97M
Current deferred revenue - - - - -
Net debt 216.69M 432.22M 384.64M 556.31M 528.97M
Short term debt 19.24M 73.58M 71.39M 133.77M 74.63M
Short long term debt 19.24M 73.58M 71.39M 133.77M 74.63M
Short long term debt total 383.97M 536.85M 564.60M 556.31M 528.97M
Other stockholder equity 17.70M 15.27M 12.00M 10.76M 9.79M
Property plant equipment 388.72M 535.60M 525.90M 530.53M 514.85M
Total current assets 258.04M 224.92M 296.08M 183.90M 157.53M
Long term investments - - - - -
Net tangible assets 3.64M 9.44M 40.01M 25.54M 30.79M
Short term investments - - - - -
Net receivables 64.07M 83.54M 73.39M 66.34M 67.89M
Long term debt 364.74M 463.27M 493.21M 422.54M 454.34M
Inventory 2.70M 10.29M 2.51M 2.44M -
Accounts payable 250.14M 192.99M 187.07M 136.92M 133.65M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -7.79800M -11.76800M -13.42700M -11.27300M -7.71700M
Additional paid in capital - - - - -
Common stock total equity - - 500.58M 498.12M 492.06M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 30.47M 32.89M 37.13M 71.75M 119.00M
Deferred long term asset charges - - - - -
Non current assets total 523.54M 675.40M 667.04M 704.90M 738.79M
Capital lease obligations - - - - -
Long term debt total 364.74M 463.27M 493.21M 422.54M 454.34M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 155.64M -63.73300M 2.00M 12.77M -55.05200M
Change to liabilities 48.62M 15.45M 49.85M -5.11100M 2.21M
Total cashflows from investing activities 155.64M -63.73300M 2.00M 12.77M -55.05200M
Net borrowings -114.22900M -29.98200M 6.96M 10.33M 0.32M
Total cash from financing activities -191.85900M -74.83600M -38.16300M -28.66800M -48.76300M
Change to operating activities 1.40M 11.95M -19.85500M 1.13M -0.53600M
Net income 69.55M 11.50M 54.19M 28.63M 31.74M
Change in cash 62.65M -75.32900M 85.50M 28.56M -62.26300M
Begin period cash flow 104.63M 179.96M 94.46M 65.89M 128.16M
End period cash flow 167.28M 104.63M 179.96M 94.46M 65.89M
Total cash from operating activities 98.71M 63.42M 121.27M 45.19M 39.47M
Issuance of capital stock - - - - -
Depreciation 32.12M 38.57M 38.80M 39.59M 35.27M
Other cashflows from investing activities 257.27M 5.79M 35.10M 45.95M 29.36M
Dividends paid 42.55M 42.99M 41.26M 37.22M 37.42M
Change to inventory - - - - -
Change to account receivables 4.04M -13.76500M -7.94600M 0.20M -8.17200M
Sale purchase of stock -35.02300M - - 0.00000M -6.25800M
Other cashflows from financing activities 1.31M 0.48M 58.50M 44.21M 147.52M
Change to netincome -57.02500M -0.28300M 6.23M -19.25200M -21.03700M
Capital expenditures 101.63M 69.52M 33.10M 33.18M 50.65M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 54.06M 13.63M 22.05M -4.83300M -6.49800M
Stock based compensation 2.64M 3.57M 2.00M 1.60M 0.43M
Other non cash items -59.61900M -10.45900M -12.34800M -26.98000M -19.80300M
Free cash flow -2.91500M -6.09900M 88.17M 12.01M -11.17500M

Fundamentals

  • Previous Close 7.72
  • Market Cap597.93M
  • Volume489771
  • P/E Ratio34.10
  • Dividend Yield6.70%
  • EBITDA-4.83100M
  • Revenue TTM1265.17M
  • Revenue Per Share TTM14.78
  • Gross Profit TTM 108.53M
  • Diluted EPS TTM0.21

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EXE
Extendicare Inc
-0.44 5.70% 7.28 34.10 22.37 0.47 6.25 0.66 11.11
DNTL
dentalcorp Holdings Ltd
0.17 2.63% 6.43 - 16.72 0.92 0.73 1.84 12.30
WELL
WELL Health Technologies Corp
0.03 0.78% 3.86 - 16.67 1.46 1.38 1.97 15.06
SIA
Sienna Senior Living Inc
-0.25 1.69% 14.57 - 45.25 1.17 2.28 2.42 20.48
DR
Medical Facilities Corporation
0.06 0.51% 11.92 30.07 11.61 0.51 2.15 0.82 5.32

Reports Covered

Stock Research & News

Profile

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates LTC homes and retirement communities, as well as home health care operations under the Extendicare, ParaMed, Extendicare Assist, and SGP Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Extendicare Inc

3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9

Key Executives

Name Title Year Born
Dr. Michael R. Guerriere M.D., MBA CEO, Pres & Director 1964
Mr. David E. Bacon Sr. VP & CFO NA
Mr. John Toffoletto Sr. VP, Chief Legal Officer & Corp. Sec. NA
Ms. Leslie Sarauer Sr. VP & Chief HR Officer 1962
Mr. Ali Mohammad Mir VP, ParaMed Operations NA
Mr. Steve Paraskevopoulos Sr. VP of ParaMed & CTO NA
Ms. Jillian E. Fountain VP of Investor Relations NA
Ms. Lisa Pearson VP of Public Affairs NA
Ms. Elaine E. Everson VP of Corp. Devel. NA
Dr. Matthew Morgan Chief Medical Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).